Prostate & Kidney Cancer
Presentations (webcasts below):
-
Survival results from STAMPEDE: Comment Ignacio Duran, Santander
- LBA6_PR - JAVELIN Renal 101: a randomized, phase 3 study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)
-
JAVELIN Renal 101: Comment John Haanen, Amsterdam